Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line.
J Toxicol Sci
; 42(3): 259-265, 2017.
Article
em En
| MEDLINE
| ID: mdl-28496032
ABSTRACT
The farnesoid X receptor (FXR) is a bile acid-activated nuclear receptor which is abundant in the liver, intestine, and kidney. FXR is a pivotal factor in cholesterol/bile acid homeostasis but is involved in the growth of hepatocellular carcinoma cells. In the present study, we investigated whether FXR is also involved in the growth of renal adenocarcinoma cells. The cell growth of renal adenocarcinoma cell line ACHN was inhibited by FXR knockdown and stimulated by FXR ligand, while that of a normal renal cell-derived cell line, HK-2, was not affected. The carcinoma-specific stimulation of cell growth by FXR was found to arise from down-regulation of p53 and p21/Cip1 mRNA expression. Our study showed that FXR stimulates proliferation of renal adenocarcinoma cells and that FXR knockdown is useful for growth suppression of renal adenocarcinoma without cytotoxicity to normal renal cells.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Adenocarcinoma
/
Transformação Celular Neoplásica
/
Receptores Citoplasmáticos e Nucleares
/
Processos de Crescimento Celular
/
Neoplasias Renais
Limite:
Adult
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Toxicol Sci
Ano de publicação:
2017
Tipo de documento:
Article